•
Mar 31, 2021
Quanterix Q1 2021 Earnings Report
Quanterix reported an increase in non-GAAP revenue and made advances on strategic priorities.
Key Takeaways
Quanterix reported Q1 2021 GAAP revenue of $27.2M. Non-GAAP revenue was $24.9M, representing a 58% increase compared to the prior year. The company is focused on innovating its technology and expanding its assay menu, particularly for early detection plasma biomarkers for Alzheimer's and neuro-degeneration.
GAAP revenue including grant revenue was $27.2M.
Non-GAAP revenue was $24.9M, up 58% year-over-year.
The company is innovating its technology and expanding its assay menu.
Quanterix is focused on early detection plasma biomarkers for Alzheimer’s and neuro-degeneration.